About US
Contact us
-
Already riding naloxone boom, Amphastar plots nasal spray to rival old formulasA surge ofopioid-related deaths in the U.S. has created an opportunity for pharma companies that make the overdose antidotenaloxone. The drug's price has risen tenfold in recent years,Bloombergreports2015/9/9
-
Novartis CEO: Payers not sold on performance pricing yet, but that'll changeNovartis ($NVS) CEO Joe Jimenez sees a couple of rays of hope for drug spending--and for the viability of higher-priced meds. Big Data, for one. And performance-based pricing for another. In an inter2015/9/9
-
UPDATED: AstraZeneca scores FDA nod for long-term Brilinta useAstraZeneca's ($AZN) blood thinnerBrilintais officially one step closer to living up to the $3.5 billion ambitions the British pharma laid out last February. TheFDAhas handed down an approval for long2015/9/7
-
India's Cipla gets U.S. beachhead with $550M deal for 2 generics operationsIndia'sCiplamade its name in the west as a leader in challenging Big Pharma patents on expensive drugs in an effort to cut their prices in a country with a large need and little money. But it has lagg2015/9/7
-
UPDATED: AstraZeneca scores FDA nod for long-term Brilinta useAstraZeneca's ($AZN) blood thinnerBrilintais officially one step closer to living up to the $3.5 billion ambitions the British pharma laid out last February. TheFDAhas handed down an approval for long2015/9/6
-
India's Cipla gets U.S. beachhead with $550M deal for 2 generics operationsIndia'sCiplamade its name in the west as a leader in challenging Big Pharma patents on expensive drugs in an effort to cut their prices in a country with a large need and little money. But it has lagg2015/9/6
-
CFDA Vice Minister Wu Zhen meets Country Director of U.S. FDA China OfficeOn the morning of August 27, 2015, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by S. Leigh Verbois, Country Director of U.S. FDA China Office. Both2015/9/2
-
Bernie Sanders proposes raft of legislation to combat rising drug pricesSen. Bernie Sanders, a longtime pharma watchdog, says he's rolling out legislation to stall drug price hikes. The presidential candidate's proposals include some previously failed measures--includingM2015/9/2
-
BMS, AbbVie nab 'breakthrough' tag for multiple myeloma-fighting antibodyA new drug for blood cancer from Bristol-Myers Squibb ($BMY) and AbbVie ($ABBV) is on the fast track to FDA approval, winning a priority review to treat multiple myeloma.Report2015/9/2
-
No change in CV risk for ACS patients on Sanofi's LyxumiaLONDON--Back in June, researchers unveiled details of the ELIXA trial, which put Sanofi's Lyxumia in the clear as far as cardiovascular safety risks go. Now, a new analysis of the study shows that in2015/9/1